Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121925482 | 12192548 | 2 | F | 20160118 | 20160707 | 20160318 | 20160715 | EXP | DE-BFARM-16083489 | DE-009507513-1603DEU007567 | MERCK | 53.00 | YR | M | Y | 100.00000 | KG | 20160715 | OT | DE | DE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121925482 | 12192548 | 1 | PS | SIMVASTATIN. | SIMVASTATIN | 1 | Oral | 40 MG, QD | Y | U | 19766 | 40 | MG | TABLET | QD | ||||
| 121925482 | 12192548 | 2 | C | BISOHEXAL | BISOPROLOL FUMARATE | 1 | 5 MG, ONCE DAILY | U | 0 | 5 | MG | QD | |||||||
| 121925482 | 12192548 | 3 | C | CO-DIOVAN | HYDROCHLOROTHIAZIDEVALSARTAN | 1 | 1X1/2, HALF A TABLET ONCE DAILY, TOTAL DAILY DOSE: 80MG/6.25MG | U | 0 | ||||||||||
| 121925482 | 12192548 | 4 | C | ALLOPURINOL. | ALLOPURINOL | 1 | 300 MG, ONCE DAILY | U | 0 | 300 | MG | QD | |||||||
| 121925482 | 12192548 | 5 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | 500 MG, TWICE DAILY | Y | U | 0 | 500 | MG | BID | ||||||
| 121925482 | 12192548 | 6 | C | SITAGLIPTIN PHOSPHATE | SITAGLIPTIN PHOSPHATE | 1 | 100 MG, ONCE DAILY | U | 0 | 100 | MG | TABLET | QD | ||||||
| 121925482 | 12192548 | 7 | C | DOXEPIN HYDROCHLORIDE. | DOXEPIN HYDROCHLORIDE | 1 | 25 MG, ONCE DAILY | U | 0 | 25 | MG | QD | |||||||
| 121925482 | 12192548 | 8 | C | LANTUS | INSULIN GLARGINE | 1 | Subcutaneous | UNK | U | 0 | |||||||||
| 121925482 | 12192548 | 9 | C | LIPROLOG | INSULIN LISPRO | 1 | Subcutaneous | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 121925482 | 12192548 | 1 | Hyperlipidaemia |
| 121925482 | 12192548 | 2 | Hypertension |
| 121925482 | 12192548 | 3 | Hypertension |
| 121925482 | 12192548 | 4 | Hyperuricaemia |
| 121925482 | 12192548 | 5 | Type 2 diabetes mellitus |
| 121925482 | 12192548 | 6 | Type 2 diabetes mellitus |
| 121925482 | 12192548 | 7 | Depression |
| 121925482 | 12192548 | 8 | Type 2 diabetes mellitus |
| 121925482 | 12192548 | 9 | Type 2 diabetes mellitus |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 121925482 | 12192548 | OT |
| 121925482 | 12192548 | LT |
| 121925482 | 12192548 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 121925482 | 12192548 | Acute kidney injury | |
| 121925482 | 12192548 | Dialysis | |
| 121925482 | 12192548 | Pneumonia | |
| 121925482 | 12192548 | Rhabdomyolysis | |
| 121925482 | 12192548 | Systemic inflammatory response syndrome | |
| 121925482 | 12192548 | Tremor |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |